Biomatter

Recent Finacing

Seed

Recent Raise

$7.1M

Biomatter designs custom enzymes and protein therapeutics using a generative AI and physics-informed platform to engineer proteins from first principles for chemical bioproduction, agriculture, food, and medicine.

Founded 2018

Vilniaus Apskritis, Lithuania

11-50

Private

biomatter.ai

Highlights

Focus Areas

Biotechnology

Pharmaceutical

Recent Investors

Financials

$7.7M

Total Raised

2

Funding rounds

5

Investors

Team

Upgrade to view the team

See the team members at Biomatter.